These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14702288)

  • 1. Promoter hypermethylation of the cyclin-dependent kinase inhibitor (CDKI) gene p21WAF1/CIP1/SDI1 is rare in various lymphomas and carcinomas.
    Ying J; Srivastava G; Gao Z; Zhang X; Murray P; Ambinder R; Tao Q
    Blood; 2004 Jan; 103(2):743-6. PubMed ID: 14702288
    [No Abstract]   [Full Text] [Related]  

  • 2. p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53.
    Fang L; Igarashi M; Leung J; Sugrue MM; Lee SW; Aaronson SA
    Oncogene; 1999 May; 18(18):2789-97. PubMed ID: 10362249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US; Park SK; Lee YI; Park JG; Lee YI
    Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
    Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA
    Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.
    el-Deiry WS; Tokino T; Waldman T; Oliner JD; Velculescu VE; Burrell M; Hill DE; Healy E; Rees JL; Hamilton SR
    Cancer Res; 1995 Jul; 55(13):2910-9. PubMed ID: 7796420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells.
    Schwaller J; Koeffler HP; Niklaus G; Loetscher P; Nagel S; Fey MF; Tobler A
    J Clin Invest; 1995 Mar; 95(3):973-9. PubMed ID: 7883998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation analysis of cyclin-dependent kinase inhibitor genes in primary gastrointestinal lymphomas.
    Go JH
    Mod Pathol; 2003 Aug; 16(8):752-5. PubMed ID: 12920218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium.
    Lukas J; Groshen S; Saffari B; Niu N; Reles A; Wen WH; Felix J; Jones LA; Hall FL; Press MF
    Am J Pathol; 1997 Jan; 150(1):167-75. PubMed ID: 9006333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax.
    Kaneuchi M; Yamashita T; Shindoh M; Segawa K; Takahashi S; Furuta I; Fujimoto S; Fujinaga K
    Mol Carcinog; 1999 Sep; 26(1):44-52. PubMed ID: 10487521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p21WAF1/CIP1 gene is inactivated in metastatic prostatic cancer cell lines by promoter methylation.
    Bott SR; Arya M; Kirby RS; Williamson M
    Prostate Cancer Prostatic Dis; 2005; 8(4):321-6. PubMed ID: 16276353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin E overexpression responsible for growth of human hepatic tumors with p21WAF1/CIP1/SDI1.
    Tsuji T; Miyazaki M; Fushimi K; Mihara K; Inoue Y; Ohashi R; Ohtsubo M; Hamazaki K; Furusako S; Namba M
    Biochem Biophys Res Commun; 1998 Jan; 242(2):317-21. PubMed ID: 9446792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the interferon-gamma/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region.
    Chen B; He L; Savell VH; Jenkins JJ; Parham DM
    Cancer Res; 2000 Jun; 60(12):3290-8. PubMed ID: 10866323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mammalian Cut homeodomain protein functions as a cell-cycle-dependent transcriptional repressor which downmodulates p21WAF1/CIP1/SDI1 in S phase.
    Coqueret O; Bérubé G; Nepveu A
    EMBO J; 1998 Aug; 17(16):4680-94. PubMed ID: 9707427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation status analysis of cell cycle regulatory genes (p16INK4A, p15INK4B, p21Waf1/Cip1, p27Kip1 and p73) in natural killer cell disorders.
    Kawamata N; Inagaki N; Mizumura S; Sugimoto KJ; Sakajiri S; Ohyanagi-Hara M; Oshimi K
    Eur J Haematol; 2005 May; 74(5):424-9. PubMed ID: 15813917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspase 3 specifically cleaves p21WAF1/CIP1 in the earlier stage of apoptosis in SK-HEP-1 human hepatoma cells.
    Park JA; Kim KW; Kim SI; Lee SK
    Eur J Biochem; 1998 Oct; 257(1):242-8. PubMed ID: 9799125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged progestin treatment induces the promoter of CDK inhibitor p21 Cip1,Waf1 through activation of p53 in human breast and endometrial tumor cells.
    Kester HA; Sonneveld E; van der Saag PT; van der Burg B
    Exp Cell Res; 2003 Apr; 284(2):264-73. PubMed ID: 12651158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p21(CIP1/WAF1/SDI1) hypermethylation: an exciting new lead in ALL biology.
    Boldt DH
    Blood; 2002 Apr; 99(7):2283. PubMed ID: 11895756
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of cell-cycle regulatory genes in HTLV-I infected T-cell lines: possible involvement of Tax1 in the altered expression of cyclin D2, p18Ink4 and p21Waf1/Cip1/Sdi1.
    Akagi T; Ono H; Shimotohno K
    Oncogene; 1996 Apr; 12(8):1645-52. PubMed ID: 8622884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional repression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 gene mediated by cis elements present in the 3'-untranslated region.
    Rishi AK; Hsu CK; Li XS; Hussain A; Gerald TM; Fontana JA
    Cancer Res; 1997 Nov; 57(22):5129-36. PubMed ID: 9371514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insensitivity to growth inhibition by TGF-beta1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cells.
    Cipriano SC; Chen YQ
    Oncogene; 1998 Sep; 17(12):1549-56. PubMed ID: 9794232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.